INCB-123667 is under clinical development by Incyte and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase I drugs for Peritoneal Cancer have an 85% phase transition success ...

Medically reviewed by Doru Paul, MD Peritoneal washing (abdominopelvic washing) is a procedure used to diagnose whether ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

In recent years, PARP inhibitors are changing the therapeutic landscape of ovarian cancer, with maintenance therapy extending the duration of sustained remission after platinum-containing chemotherapy ...

Ovarian cancer starts in one or both ovaries, or in the fallopian tubes, or in the abdominal lining called the peritoneum. Women between the ages of 55 and 63 are most likely to get ovarian cancer.

PNN New Delhi [India] January 8 Thangam Cancer Center Namakkal is organizing a three days conference on peritoneal surface ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

Zentalis Pharmaceuticals has won a U.S. Food and Drug Administration fast-track designation for its lead product candidate azenosertib for certain cancer patients with high levels of the Cyclin E1 ...

"This is the first time researchers have been able to indirectly target ovarian cancer cells in peritoneal fluid by inducing an immune reaction, in preclinical models," said Zhang. "We look ...